Literature DB >> 32628595

Anticancer Active Heterocyclic Chalcones: Recent Developments.

Prasad Dandawate1, Khursheed Ahmed2, Subhash Padhye1, Aamir Ahmad3, Bernhard Biersack4.   

Abstract

BACKGROUND: Chalcones are structurally simple compounds that are easily accessible by synthetic methods. Heterocyclic chalcones have gained the interest of scientists due to their diverse biological activities. The anti-tumor activities of heterocyclic chalcones are especially remarkable and the growing number of publications dealing with this topic warrants an up-to-date compilation.
METHODS: Search for antitumor active heterocyclic chalcones was carried out using Pubmed and Scifinder as common web-based literature searching tools. Pertinent and current literature was covered from 2015/2016 to 2019. Chemical structures, biological activities and modes of action of anti-tumor active heterocyclic chalcones are summarized.
RESULTS: Simply prepared chalcones have emerged over the last years with promising antitumor activities. Among them, there are a considerable number of tubulin polymerization inhibitors. But there are also new chalcones targeting special enzymes such as histone deacetylases or with DNA-binding properties.
CONCLUSION: This review provides a summary of recent heterocyclic chalcone derivatives with distinct antitumor activities. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Chalcone; anticancer agents; drug design; heterocycle; histone deacetylase; tubulin

Year:  2021        PMID: 32628595     DOI: 10.2174/1871520620666200705215722

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  3 in total

1.  Antitubercular activity assessment of fluorinated chalcones, 2-aminopyridine-3-carbonitrile and 2-amino-4H-pyran-3-carbonitrile derivatives: In vitro, molecular docking and in-silico drug likeliness studies.

Authors:  Surendra Babu Lagu; Rajendra Prasad Yejella; Srinath Nissankararao; Richie R Bhandare; Venu Sampath Golla; Bontha Venkata Subrahmanya Lokesh; M Mukhlesur Rahman; Afzal Basha Shaik
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

2.  Quantitative and Qualitative Analysis of the Anti-Proliferative Potential of the Pyrazole Scaffold in the Design of Anticancer Agents.

Authors:  George Mihai Nitulescu
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

Review 3.  Curcumin: reclaiming the lost ground against cancer resistance.

Authors:  Siraj Shaikh; Javed Shaikh; Yusufi Sadia Naba; Kailas Doke; Khursheed Ahmed; Mujahid Yusufi
Journal:  Cancer Drug Resist       Date:  2021-06-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.